Cargando…

Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage

Angiogenesis and increased permeability are essential pathological basis for the development of ovarian hyperstimulation syndrome (OHSS). Kallistatin (KS) is an endogenous anti‐inflammatory and anti‐angiogenic factor that participates in a variety of diseases, but its role in OHSS remains unknown. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jianfang, Mao, Yuling, Li, Quanxin, Hong, Honghai, Tang, Ni, Kang, Xiangjin, Huang, Yuling, Liu, Jianqiao, Gong, Qing, Yao, Yachao, Li, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357611/ https://www.ncbi.nlm.nih.gov/pubmed/35866203 http://dx.doi.org/10.1111/jcmm.17491

Ejemplares similares

Kallistatin - the score beats the marker
por: Draikiwicz, Steven, et al.
Publicado: (2013)

Crystallization and crystallographic studies of kallistatin
por: Lin, Fang, et al.
Publicado: (2015)

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

Prevention of Ovarian Hyperstimulation Syndrome: A Review
por: Smith, Vinayak, et al.
Publicado: (2015)

Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
por: Yao, Yuyu, et al.
Publicado: (2018)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2019)

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome
por: Alama, Pilar, et al.
Publicado: (2013)

Increased serum kallistatin levels in type 1 diabetes patients with vascular complications
por: Jenkins, Alicia J, et al.
Publicado: (2010)

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2020)

Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway
por: Chao, Julie, et al.
Publicado: (2017)

Novel Role of Kallistatin in Vascular Repair by Promoting Mobility, Viability, and Function of Endothelial Progenitor Cells
por: Gao, Lin, et al.
Publicado: (2014)

The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm
por: Li, Jiaze, et al.
Publicado: (2016)

Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation
por: Chao, Julie, et al.
Publicado: (2018)

Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome
por: Zhang, Qiaoli, et al.
Publicado: (2022)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome
por: Naredi, Nikita, et al.
Publicado: (2013)

Effects of SARS-CoV-2 infection on embryological outcomes in assisted reproductive technology during the Omicron epidemic
por: Mao, Yuling, et al.
Publicado: (2023)

Electroacupuncture Reduces Oocyte Number and Maintains Vascular Barrier Against Ovarian Hyperstimulation Syndrome by Regulating CD200
por: Chen, Li, et al.
Publicado: (2021)

Kallistatin reduces vascular senescence and aging by regulating microRNA‐34a‐SIRT1 pathway
por: Guo, Youming, et al.
Publicado: (2017)

Cell surface expression of nucleolin mediates the antiangiogenic and antitumor activities of kallistatin
por: Huang, Xiao-Ping, et al.
Publicado: (2017)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy
por: Di Guardo, Federica, et al.
Publicado: (2023)

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin
por: Shiau, Ai-Li, et al.
Publicado: (2010)

Clinical Features of Severe Ovarian Hyperstimulation Syndrome with Hydrothorax
por: Ma, Xiaowei, et al.
Publicado: (2023)

Microvascular density and vascular endothelial growth factor and osteopontin expression during the implantation window in a controlled ovarian hyperstimulation rat model
por: GONG, XIN, et al.
Publicado: (2015)

Ovarian Hyperstimulation Syndrome: Current Views on Pathophysiology, Risk Factors, Prevention, and Management
por: Alper, Michael M, et al.
Publicado: (2009)

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment
por: Fiedler, Klaus, et al.
Publicado: (2012)

Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy
por: Marak, Creticus P., et al.
Publicado: (2013)

Radiological Illustration of Spontaneous Ovarian Hyperstimulation Syndrome
por: Mittal, Kartik, et al.
Publicado: (2015)

Zika virus during controlled ovarian hyperstimulation
por: Joob, Beuy, et al.
Publicado: (2019)

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
por: Gómez, Gemma Grau, et al.
Publicado: (2019)

Plasma kallistatin levels in patients with severe community-acquired pneumonia
por: Lin, Wei-Chieh, et al.
Publicado: (2013)

Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis
por: Cheng, Zhiyun, et al.
Publicado: (2015)

Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells
por: Muhammad, Fauziyya, et al.
Publicado: (2020)

Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation
por: Huang, Ying, et al.
Publicado: (2014)

Electroacupuncture facilitates implantation by enhancing endometrial angiogenesis in a rat model of ovarian hyperstimulation
por: Chen, Wei, et al.
Publicado: (2019)

Lipid Metabolic Disorders and Ovarian Hyperstimulation Syndrome: A Retrospective Analysis
por: Liu, Feifei, et al.
Publicado: (2020)

Comparison of albumin and cabergoline in the prevention of ovarian hyperstimulation syndrome: A clinical trial study
por: Torabizadeh, Aalie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5khdnupdmdtesu2n3l2phkd2vk